Page 4 - Bionic Sight News Today

Fox News Flash top headlines are here. Check out whats clicking on Foxnews.com. Scientists are making dramatic strides toward a goal that once seemed almost unimaginable: Restoring limited vision to people affected by a previously irreversible form of blindness caused by an inherited eye disease called retinitis pigmentosa. In a paper published Monday in the journal Nature Medicine, researchers working with the Paris-based company GenSight Biologics SA reported that a 58-year-old man who was di...

Adobe Somewhere in Paris, in a white room, seated at a white table, a man wearing a headset reminiscent of those worn by VR gamers reached out with his right hand and placed his fingers on a black notebook. This simple motion, which he executed with confidence, was notable for one very important reason: The man had been blind for close to four decades. What was different now was that as part of a clinical trial, genes had been injected into one of his eyes, causing neurons in the retina to prod...

Sahel et al, Nature Medicine and StreetLab/Institut de la Vision A man who is blind has had glimmers of vision restored thanks to a high-tech treatment using optogenetics, which involves genetically altering nerve cells so they respond to light. French firm GenSight Biologics has published results showing that the first recipient of its treatment can recognise different objects in lab tests. “It’s exciting to see the first publication on human optogenetics,” says Ed Boyden at the Massachu...

Share A blind man who received a gene from algae in one eye reaches for a notebook with the help of special goggles. J.A. Sahel et. al., Blind man regains some vision, with help from light-sensing algal protein May. 24, 2021 , 12:20 PM A blind man who received a gene for a light-sensing algal protein can now see and touch objects with the help of special goggles, researchers report today. His vision gains are modest—he cannot see colors or discern faces or letters. But if the treatmen...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. AGTC Clinical Investigators Provide Encore Presentation of Data from the Company’s Ongoing XLRP ... Applied Genetic Technologies CorporationMay 3, 2021 GMT -Company remains on track to present additional 12-month data from the XLRP and achromatopsia clinical trials in the second quarter of 2021- ALACHUA, Fla. and CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corpora...

Latest research report, titled “Global Vision Care Devices Market Insights 2021 and Forecast 2026, This includes overview and deep study of factors wh

FinancialContent fully hosted finance channel